Retrieve Medical Holdings Price to Sales Ratio 2010-2024 | RMHI
Historical PS ratio values for Retrieve Medical Holdings (RMHI) over the last 10 years. The current P/S ratio for Retrieve Medical Holdings as of April 23, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Retrieve Medical Holdings P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-04-22 | 3.50 | 0.00 | |
| 2024-09-30 | 2.57 | 0 | 0.00 |
| 2024-06-30 | 2.20 | 0 | 0.00 |
| 2024-03-31 | 3.70 | 0 | 0.00 |
| 2023-12-31 | 1.73 | 0 | 0.00 |
| 2023-09-30 | 3.95 | 0 | 0.00 |
| 2023-06-30 | 2.75 | 0 | 0.00 |
| 2023-03-31 | 3.77 | 0 | 0.00 |
| 2022-12-31 | 0.14 | 0 | 0.00 |
| 2022-09-30 | 0.06 | 0 | 0.00 |
| 2022-06-30 | 0.06 | 0 | 0.00 |
| 2022-03-31 | 0.08 | 0 | 0.00 |
| 2021-12-31 | 0.08 | 0 | 0.00 |
| 2021-09-30 | 0.13 | 0 | 0.00 |
| 2021-06-30 | 0.12 | 0 | 0.00 |
| 2021-03-31 | 0.14 | 0 | 0.00 |
| 2020-12-31 | 0.08 | 0 | 0.00 |
| 2020-09-30 | 0.01 | 0 | 0.00 |
| 2020-06-30 | 0.02 | 0 | 0.00 |
| 2020-03-31 | 0.01 | 0 | 0.00 |
| 2019-12-31 | 0.01 | 0 | 0.00 |
| 2019-09-30 | 0.01 | 0 | 0.00 |
| 2019-06-30 | 0.04 | 0 | 0.00 |
| 2019-03-31 | 0.09 | 0 | 0.00 |
| 2018-12-31 | 0.12 | 0 | 0.00 |
| 2018-09-30 | 0.13 | 0 | 0.00 |
| 2018-06-30 | 0.14 | 0 | 0.00 |
| 2018-03-31 | 0.09 | 0 | 0.00 |
| 2017-12-31 | 0.15 | 0 | 0.00 |
| 2017-09-30 | 0.03 | 0 | 0.00 |
| 2017-06-30 | 0.04 | 0 | 0.00 |
| 2017-03-31 | 0.06 | 0 | 0.00 |
| 2016-12-31 | 0.04 | 0 | 0.00 |
| 2016-09-30 | 0.03 | 0 | 0.00 |
| 2016-06-30 | 0.02 | 0 | 0.00 |
| 2016-03-31 | 0.01 | 0 | 0.00 |
| 2015-12-31 | 0.03 | 0 | 0.00 |
| 2015-09-30 | 0.05 | 0 | 0.00 |
| 2015-06-30 | 0.12 | 0 | 0.00 |
| 2015-03-31 | 0.23 | 0 | 0.00 |
| 2014-12-31 | 0.20 | 0 | 0.00 |
| 2014-09-30 | 0.51 | 0 | 0.00 |
| 2014-06-30 | 0.94 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.082B | $0.000B |
| Retrieve Medical Inc. is a software company. It is commercializing a patented Clinical Documentation Improvement platform, Retrieve Dx(TM), which enhances physician ability to quickly understand the complex clinical history of patients and diagnose chronic conditions by analyzing physician notes, lab results, radiology reports, EKG interpretations and more. Retrieve Medical Inc., formerly known as Peak Pharmaceuticals Inc., is based in SCOTTSDALE, AZ. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $35.134B | 48.53 |
| Tempus AI (TEM) | United States | $6.966B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $6.050B | 97.25 |
| Inspire Medical Systems (INSP) | United States | $4.470B | 86.83 |
| IRhythm Technologies (IRTC) | United States | $3.223B | 0.00 |
| Privia Health (PRVA) | United States | $2.873B | 215.27 |
| Schrodinger (SDGR) | United States | $1.881B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.839B | 0.00 |
| Enovis (ENOV) | United States | $1.825B | 11.29 |
| Omnicell (OMCL) | United States | $1.418B | 30.59 |
| Phreesia (PHR) | United States | $1.409B | 0.00 |
| Azenta (AZTA) | United States | $1.154B | 53.72 |
| 10x Genomics (TXG) | United States | $0.918B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.568B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.551B | 0.00 |
| Talkspace (TALK) | United States | $0.450B | 267.00 |
| Veradigm (MDRX) | United States | $0.449B | 0.00 |
| Standard BioTools (LAB) | United States | $0.440B | 0.00 |
| TruBridge (TBRG) | United States | $0.363B | 0.00 |
| Claritev (CTEV) | United States | $0.325B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.270B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.206B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.189B | 0.00 |
| Pulmonx (LUNG) | United States | $0.182B | 0.00 |
| American Well (AMWL) | United States | $0.109B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.100B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.076B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.066B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| CareCloud (CCLD) | United States | $0.060B | 2.58 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| Outset Medical (OM) | United States | $0.040B | 0.00 |
| Zepp Health (ZEPP) | China | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.030B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Syra Health (SYRA) | United States | $0.001B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |